✦ LIBER ✦

Soluble Receptor Activator of Nuclear Factor-κB Ligand (sRANKL)/Osteoprotegerin Balance in Ageing and Age-Associated Diseases

✍ Scribed by Lia Pulsatelli; Paolo Dolzani; Tania Silvestri; Paolo Caraceni; Andrea Facchini; Giovanni Ravaglia; Carlo Salvarani; Riccardo Melicòni; Erminia Mariani

Book ID: 111573031
Publisher: Springer
Year: 2004
Tongue: English
Weight: 112 KB
Volume: 5
Category: Article
ISSN: 1389-5729
DOI: 10.1023/b:bgen.0000025075.04136.ec

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential expression of receptor acti

Differential expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA in periodontal diseases

✍ N. Bostancı; T. İlgenli; G. Emingil; B. Afacan; B. Han; H. Töz; A. Berdeli; G. A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Receptor activator of nuclear factor κB

Receptor activator of nuclear factor κB ligand and osteoprotegerin in men with thyroid cancer

✍ P. Mikosch; I. Igerc; S. Kudlacek; W. Woloszczuk; H. J. Gallowitsch; E. Kresnik; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Role of receptor activator of nuclear fa

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

✍ Lorenz C. Hofbauer; Armin E. Heufelder 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 119 KB

Plasma and drainage fluid levels of solu

Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing

✍ Alessandra Colombini; Giovanni Lombardi; Emanuela Galliera; Giada Dogliotti; Pie 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 271 KB

Plasma levels of receptor activator of n

Plasma levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in patients with neuroblastoma

✍ Donatella Granchi; Alberto Garaventa; Ilaria Amato; Paolo Paolucci; Nicola Baldi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB

## Abstract Earlier reports showed that the balance between receptor activator of nuclear factor‐κB ligand (RANKL) and its decoy‐receptor osteoprotegerin (OPG) plays an important role in the pathogenesis of metastatic osteolysis induced by neuroblastoma cells. In this study, we investigated whether

Receptor activator of nuclear factor-κB

Receptor activator of nuclear factor-κB ligand and osteoprotegerin : Potential implications for the pathogenesis and treatment of malignant bone diseases

✍ Lorenz C. Hofbauer; Andreas Neubauer; Armin E. Heufelder 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

## Background: The current review summarizes the roles of the ligand, receptor activator of nuclear factor-kappab ligand (rankl), its receptor, receptor activator of nuclear factor-kappab (rank), and its decoy receptor, osteoprotegerin (opg), on osteoclast biology and bone resorption. furthermore,